Skip to main content

Advertisement

Table 1 Clinical variables of the 101 hypertensive patients with or without metabolic syndrome

From: Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients

Variables All participants (n = 101) No metabolic syndrome (n = 38) Metabolic syndrome (n = 63) P value
Age (years) 64.88 ± 9.58 66.13 ± 10.14 64.13 ± 9.23 0.311
Height (cm) 161.27 ± 8.36 162.22 ± 7.24 160.70 ± 8.98 0.377
Body weight (kg) 69.73 ± 13.01 63.34 ± 10.80 73.59 ± 12.78 <0.001*
Waist circumference (cm) 93.37 ± 11.55 84.82 ± 9.44 98.52 ± 9.50 <0.001*
Body mass index (kg/m2) 26.71 ± 3.87 23.99 ± 3.24 28.34 ± 3.27 <0.001*
Left baPWV (m/s) 15.22 ± 3.45 12.65 ± 3.06 16.77 ± 2.67 <0.001*
Right baPWV (m/s) 15.32 ± 3.69 12.46 ± 3.01 17.04 ± 2.91 <0.001*
Systolic blood pressure (mmHg) 133.44 ± 16.68 128.21 ± 13.70 136.59 ± 17.60 0.014*
Diastolic blood pressure (mmHg) 74.52 ± 10.73 72.34 ± 10.64 75.84 ± 10.65 0.113
Pulse pressure (mmHg) 58.91 ± 14.92 55.87 ± 12.71 60.75 ± 15.92 0.112
Total cholesterol (mg/dL) 174.10 ± 40.81 176.95 ± 39.80 172.38 ± 41.62 0.588
Triglycerides (mg/dL) 127.00 (91.00–177.00) 107.00 (73.75–128.50) 150.00 (104.00–218.00) <0.001*
HDL-C (mg/dL) 45.06 ± 13.07 50.08 ± 14.25 42.03 ± 11.39 0.002*
LDL-C (mg/dL) 102.29 ± 31.55 105.16 ± 31.71 100.56 ± 31.58 0.480
Fasting glucose (mg/dL) 108.00 (96.00–145.50) 97.50 (89.75–115.25) 122.00 (103.00–161.00) <0.001*
Blood urea nitrogen (mg/dL) 17.38 ± 5.73 16.13 ± 3.97 18.13 ± 6.48 0.090
Creatinine (mg/dL) 1.13 ± 0.32 1.09 ± 0.28 1.15 ± 0.35 0.318
Glomerular filtration rate (mL/min) 68.93 ± 19.98 72.82 ± 19.55 66.59 ± 20.02 0.130
Total calcium (mg/dL) 9.14 ± 0.38 9.03 ± 0.38 9.20 ± 0.36 0.035*
Phosphorus (mg/dL) 3.51 ± 0.52 3.40 ± 0.46 3.58 ± 0.55 0.095
Calcium-phosphorous product (mg2/dL2) 32.09 ± 5.25 30.71 ± 4.66 32.92 ± 5.45 0.041*
Intact parathyroid hormone (pg/mL) 46.35 (32.40–61.90) 49.60 (34.25–67.58) 44.15 (28.88–57.55) 0.009*
C-reactive protein (mg/dL) 0.20 (0.14–0.27) 0.16 (0.12–0.19) 0.24 (0.17–0.36) <0.001*
Insulin (uIU/mL) 11.99 (7.98–25.16) 9.86 (6.06–15.14) 15.22 (9.22–28.99) 0.004*
HOMA1-IR 3.57 (2.27–7.45) 2.37 (1.50–4.58) 4.35 (2.93–8.72) 0.001*
HOMA2-IR 1.63 (1.10–3.30) 1.32 (0.81–1.97) 2.14 (1.33–3.91) 0.002*
Adiponectin (μg/mL) 28.40 (23.09–39.90) 36.92 (26.53–47.17) 25.55 (21.00–33.66) <0.001*
Female (%) 34 (33.7) 9 (23.7) 25 (39.7) 0.099
Diabetes (%) 44 (43.6) 9 (23.7) 35 (55.6) 0.002*
  1. Values for continuous variables given as mean ± standard deviation and compared by Student’s t test; variables not normally distributed given as medians and interquartile range and compared by Mann–Whitney U test; values are presented as number (%), and analysis was performed using the Chi square test
  2. baPWV brachial-ankle pulse wave velocity, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, HOMA-IR homeostasis model assessment of insulin resistance
  3. * P < 0.05 was considered statistically significant